| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |